Pretest - Tumor Board Tuesday - January 11, 2022 (ID: i788-24)

Question Title

* 1. Please list your first name, last name, and email:

First name:

Last name:

Email:

Question Title

* 2. What is your specialty?

Question Title

* 3. Testing for ctDNA is commercially available for patients who have undergone resection of a colorectal cancer

True

False

Question Title

* 4. A 64 year old male with no comorbidities has undergone resection of a colorectal cancer. Pathology revealed a pT3, pN1b (3/24 LNs) moderately differentiated adenocarcinoma. Post-operative ctDNA was undetectable.

The guideline-recommended next approach for this patient is:

No adjuvant chemo

Adjuvant capecitabine

3 months of adjuvant CAPEOX

3 months of adjuvant FOLFOX